Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Ropivacaine in Thoracic Paravertebral Block
NCT03721406Completed
- Sponsor
- Attikon University Hospital
- Start
- Oct 2019
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Attikon University Hospital. Primary endpoint: Ropivacaine plasma levels up to 72 hours. Started Oct 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03721406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03721406.